Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial
City of Hope Medical Center
City of Hope Medical Center
National Cancer Institute (NCI)
City of Hope Medical Center
Fred Hutchinson Cancer Center
Mayo Clinic
Roswell Park Cancer Institute
Elephas
University of Washington
University of Michigan Rogel Cancer Center
University of Colorado, Denver
Fondazione Policlinico Universitario Agostino Gemelli IRCCS